Article Details

Celldex Presents Positive Preclinical Data from PD-1/ILT4 Bispecific Antibody Program CDX ...

Retrieved on: 2021-11-13 15:36:40

Tags for this article:

Click the tags to see associated articles and topics

Celldex Presents Positive Preclinical Data from PD-1/ILT4 Bispecific Antibody Program CDX .... View article details on HISWAI: https://www.biospace.com/article/releases/celldex-presents-positive-preclinical-data-from-pd-1-ilt4-bispecific-antibody-program-cdx-585-at-sitc-2021/

Excerpt

About Celldex Therapeutics, Inc. Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that ...

Article found on: www.biospace.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up